The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


10 mg/ml +5 milligram(s)/millilitre Eye drops, suspension

Novartis Europharm LimitedEU/1/08/482/1-2

Main Information

Trade NameAZARGA
Active SubstancesTIMOLOL MALEATE
Strength10 mg/ml +5 milligram(s)/millilitre
Dosage FormEye drops, suspension
Licence HolderNovartis Europharm Limited
Licence NumberEU/1/08/482/1-2

Group Information

ATC CodeS01ED Beta blocking agents1)
S01ED51 timolol, combinations


Licence Issued25/11/2008
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back